Live Webinar: Identifying Human Protein Targets for COVID-19 Treatment - Labinsights

Live Webinar: Identifying Human Protein Targets for COVID-19 Treatment

icon.highlightedarticle.dark Management
Last modified: 8 May 2023
Article image of: Live Webinar: Identifying Human Protein Targets for COVID-19 Treatment

March 18th at 9AM (PT), 12-noon (ET) and 16:00 (GMT)

Brian Shoichet, Ph.D.
Professor, Pharmaceutical Chemistry, UCSF
Nevan Krogan, Ph.D.
Professor, Cellular Molecular Pharmacology, UCSF

In this webinar, UCSF professors Brian Shoichet and Nevan Krogan will discuss their work in mapping out virus-human protein interactions, and the subsequent identification of known drugs that exhibit antiviral activities by targeting human proteins.

Discussion topics will include:

What are the pros and cons of hitting a target directly interacting with SAR-CoV-2?
How to think about the timelines and impact of de novo drug discovery vs repurposing vs vaccine development?
What could be done to scale/coordinate collaborations like these for COVID-19 globally, to avoid or minimize redundant efforts?

Written by

Collaborative Drug Discovery

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers... Read more